Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways
Naunyn-Schmiedeberg's Archives of Pharmacology · 29.07.2026
DOI: 10.1007/s00210-026-05726-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 29.07.2026. Verfasst von Ahmed G Abd Elhameed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
Amiodarone-induced pulmonary fibrosis (AIPF) is characterized by inflammation, oxidative stress, microRNA dysregulation, fibroblast activation, and excessive extracellular matrix deposition. Norcantharidin (NCTD), a small-molecule compound with reported anti-inflammatory, antioxidant, and antifibrotic properties, has attracted attention as a potential therapeutic agent. To investigate the protective effects of NCTD against AIPF in rats. Eighteen rats were randomly divided into three groups (n = 6 each): a negative control group receiving vehicle, an amiodarone group, and an NCTD-treated group receiving 0.1 mg/kg intraperitoneally for six weeks. Pulmonary fibrosis was induced by oral administration of 50 mg/kg amiodarone for five weeks. Lung injury was assessed using hematoxylin and eosin staining and semi-quantitative scoring, collagen deposition was evaluated by Masson's trichrome staining, and immunohistochemistry was performed for fibronectin and α-smooth muscle actin (α-SMA). Molecular and biochemical markers including tumor necrosis factor (TNF)-α, β-catenin, interleukin (IL)-1β, malondialdehyde (MDA), and glutathione (GSH) were measured, while glycogen synthase kinase (GSK)-3β was assessed by Western blot, and miRNA-30a by quantitative PCR. Amiodarone significantly increased lung injury scores, collagen deposition, α-SMA, fibronectin, TNF-α, IL-1β, MDA, GSK-3β, and β-catenin, while reducing GSH and miRNA-30a levels. NCTD treatment markedly reversed these alterations, restoring α-SMA, fibronectin, TNF-α, IL-1β, MDA, GSK-3β, and β-catenin, while increasing GSH and miRNA-30a toward normal. Histologically, NCTD preserved alveolar architecture, reduced peribronchiolar inflammation, and normalized collagen distribution. These results demonstrate that NCTD exerts potent antifibrotic, anti-inflammatory, and antioxidant effects in AIPF, likely through modulation of oxidative stress, inflammatory cytokines, microRNA expression, and the GSK-3β/β-catenin signaling pathway, highlighting its potential as a therapeutic agent for drug-induced lung injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
- Pharmacology and Biochemistry Department, Faculty of Pharmacy, Horus University-Egypt, Damietta, Egypt.
- Pharmacy Practice Department, Faculty of Pharmacy, Horus University-Egypt, Damietta, Egypt.
- Pharmacy Practice Department, Faculty of Pharmacy, Mansoura National University, Gamasa, Egypt.
- Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia. aaalrashidi@pnu.edu.sa.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura National University, Gamasa, Egypt.
Zitieren
APA
Elhameed, A. G. A., Yousef, E. H., Salahuddin, M. M., Bahaa, M. M., Alrashidi, A. A., & El-Gammal, M. A. (2026). Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05726-7
Vancouver
Elhameed AGA, Yousef EH, Salahuddin MM, Bahaa MM, Alrashidi AA, El-Gammal MA. Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05726-7
BibTeX
@article{Elhameed2026,
author = {Elhameed, Ahmed G Abd and Yousef, Eman H and Salahuddin, Muhammed M and Bahaa, Mostafa M and Alrashidi, Amal Abdullah and El-Gammal, Mohamad A},
title = {Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05726-7}
}
EUVIMED